triazoles has been researched along with Proliferative Vitreoretinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, H; Tang, L; Wu, W; Xia, X; Xu, H; Yao, F | 1 |
| Wiedemann, P | 1 |
2 other study(ies) available for triazoles and Proliferative Vitreoretinopathy
| Article | Year |
|---|---|
Normal vitreous promotes angiogenesis via activation of Axl.
Topics: Animals; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; CRISPR-Cas Systems; Diabetic Retinopathy; Enzyme Activation; HEK293 Cells; Humans; Mice; Neovascularization, Pathologic; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Retinal Vessels; Triazoles; Vitreoretinopathy, Proliferative; Vitreous Body | 2021 |
1998 Jules Gonin lecture of the Retina Research Foundation. Drug treatment of ocular neovascularization and proliferation.
Topics: Calcium Channel Blockers; Cell Adhesion; Cell Movement; Cell Survival; Daunorubicin; Humans; Immunotoxins; Integrins; Multicenter Studies as Topic; Peptides, Cyclic; Pigment Epithelium of Eye; Retinal Neovascularization; Triazoles; Vitreoretinopathy, Proliferative | 1999 |